MoonLake Capital Surpluse vs Net Receivables Analysis
| MLTX Stock | USD 40.66 0.38 0.93% |
MoonLake Immunotherapeuti financial indicator trend analysis is infinitely more than just investigating MoonLake Immunotherapeuti recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MoonLake Immunotherapeuti is a good investment. Please check the relationship between MoonLake Immunotherapeuti Capital Surpluse and its Net Receivables accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Capital Surpluse vs Net Receivables
Capital Surpluse vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MoonLake Immunotherapeuti Capital Surpluse account and Net Receivables. At this time, the significance of the direction appears to have pay attention.
The correlation between MoonLake Immunotherapeuti's Capital Surpluse and Net Receivables is -0.95. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Net Receivables in the same time period over historical financial statements of MoonLake Immunotherapeutics, assuming nothing else is changed. The correlation between historical values of MoonLake Immunotherapeuti's Capital Surpluse and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of MoonLake Immunotherapeutics are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Capital Surpluse i.e., MoonLake Immunotherapeuti's Capital Surpluse and Net Receivables go up and down completely randomly.
Correlation Coefficient | -0.95 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Capital Surpluse
Net Receivables
Most indicators from MoonLake Immunotherapeuti's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MoonLake Immunotherapeuti current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Enterprise Value is likely to rise to about 2.6 B in 2024, whereas Selling General Administrative is likely to drop slightly above 18.3 M in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 5.0K | 12.4K | 13.2K | 11.2K | Research Development | 35.5M | 42.0M | 31.8M | 29.2M |
MoonLake Immunotherapeuti fundamental ratios Correlations
Click cells to compare fundamentals
MoonLake Immunotherapeuti Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MoonLake Immunotherapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MoonLake Immunotherapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moonlake Immunotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moonlake Immunotherapeutics Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for MoonLake Stock analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is MoonLake Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MoonLake Immunotherapeuti. If investors know MoonLake will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MoonLake Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Return On Assets (0.12) | Return On Equity (0.15) |
The market value of MoonLake Immunotherapeuti is measured differently than its book value, which is the value of MoonLake that is recorded on the company's balance sheet. Investors also form their own opinion of MoonLake Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is MoonLake Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MoonLake Immunotherapeuti's market value can be influenced by many factors that don't directly affect MoonLake Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MoonLake Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if MoonLake Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MoonLake Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.